SIAD Healthcare SIGNS Exclusive Distribution Agreement for Vergenix™FG

Assago, June 22 2018

 

 

SIAD Healthcare S.p.A. signs an agreement with CollPlant, a regenerative medicine company, for the distribution of Vergenix™FG, an innovative bio-degradable wound care device.

Vergenix™FG,  is based on rhCollagen (recombinant human collagen) that is produced within CollPlant’s proprietary plants based genetic engineering technology.

 

For further information please visit: www.collplant.com

According to the legislative decree 46/97 and the Ministry of Health Guide Lines from 17th February 2010, the promotional content concerning SIAD Healthcare products are restricted to clinical professionals. More details.
Close